Carolinas Wealth Consulting’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-29
Closed -$1.75K 177
2025
Q1
$1.75K Hold
29
﹤0.01% 831
2024
Q4
$1.99K Buy
+29
New +$2.02K ﹤0.01% 834
2024
Q3
Sell
-32
Closed -$2.22K 1058
2024
Q2
$2.22K Sell
32
-5
-14% -$365 ﹤0.01% 779
2024
Q1
$2.97K Sell
37
-9
-20% -$802 ﹤0.01% 727
2023
Q4
$5.01K Sell
46
-4
-8% -$414 ﹤0.01% 620
2023
Q3
$4.84K Sell
50
-5
-9% -$575 ﹤0.01% 608
2023
Q2
$7.49K Sell
55
-18
-25% -$2.2K ﹤0.01% 630
2023
Q1
$7.6K Buy
73
+32
+78% +$3.1K ﹤0.01% 642
2022
Q4
$3.64K Hold
41
﹤0.01% 729
2022
Q3
$3K Hold
41
﹤0.01% 710
2022
Q2
$4K Hold
41
﹤0.01% 673
2022
Q1
$6K Sell
41
-29
-41% -$4.05K ﹤0.01% 674
2021
Q4
$10K Sell
70
-1
-1% -$142 ﹤0.01% 605
2021
Q3
$9K Buy
71
+4
+6% +$523 ﹤0.01% 592
2021
Q2
$9K Sell
67
-1
-1% -$137 ﹤0.01% 614
2021
Q1
$9K Buy
68
+25
+58% +$3.01K ﹤0.01% 625
2020
Q4
$5K Sell
43
-3
-7% -$284 ﹤0.01% 642
2020
Q3
$4K Buy
+46
New +$3.75K ﹤0.01% 586

Other funds holding CNMD

Carolinas Wealth Consulting's CNMD Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of CONMED (CNMD) in Q2 2025, closing a stake of 29 shares — an estimated $1.75K sold.

Carolinas Wealth Consulting first reported a position in CNMD in Q3 2020 and held it in 18 quarters. The position peaked at $10K in Q4 2021. 277 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 29 CONMED shares in Q2 2025, an estimated $1.75K.
  • Carolinas Wealth Consulting first reported a position in CONMED in Q3 2020 and held it in 18 quarters.
  • Carolinas Wealth Consulting's CONMED position peaked at $10K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.